[SYRE] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -13.93%
YoY- -37.39%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 0 0 1,510 982 859 0 0 -
PBT -18,728 -17,167 -8,119 -6,247 -4,547 -2,468 -1,520 51.91%
Tax 0 0 0 0 0 0 0 -
NP -18,728 -17,167 -8,119 -6,247 -4,547 -2,468 -1,520 51.91%
Tax Rate - - - - - - - -
Total Cost 18,728 17,167 9,629 7,229 5,406 2,468 1,520 51.91%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 0.00 0.00 -537.68 -636.15 -529.34 0.00 0.00 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -14.15 -14.79 -12.17 -11.68 -9.95 -9.88 -5.57 16.79%
EPS Diluted -14.15 -14.79 -12.17 -11.68 -9.95 -9.88 -5.57 16.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.